Waters (WAT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Waters Corporation  (NYSE: WAT)
 

Waters Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Waters Corporation inventory turnover ratio, the Waters Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2 in the second quarter 2026, yet the ratio remained below the average, as WAT's market remain challenging.Average inventory processing period, for the Waters in Jul 04 2026 quarter, has decreased to 183 days, compare to 224 days, in the Apr 04 2026 quarter.

Within Healthcare sector 206 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1672, from total ranking in the first quarter 2026 at 1795.

WAT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Waters Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WAT Inventory Turnover Ratio (Jul 04 2026)
II. Quarter		 (Apr 04 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Inventory Growth 154.64 % 192.47 % 19.93 % 10.39 % 3.41 %
Y / Y Cost of Sales Growth 354.38 % 210.87 % 4.12 % -30.17 % -30.44 %
Inventory Turnover Ratio (TTM) 2 1.63 1.72 1.77 1.99
WAT's Total Ranking # 1672 # 1795 # 1691 # 1606 # 1544
Average inventory processing period 183 224 213 207 183
Seq. Inventory Growth -7.95 % 161.37 % -0.1 % 5.95 % 5.72 %
Seq. Cost of Sales Growth 73.85 % 44.41 % 72.27 % 5.06 % 18.95 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 207
Overall Market # 1672

Inventory Turnover Ratio Statistics
High Average Low
3.49 2.79 1.61
(Dec. 30. 2007)   (Oct 01 2016)



WAT Company Profile >> Back to WAT Efficiency Comparisons >> Compare WAT Inventory Turnover Ratio to its Competitors

Financial Statements
Waters's Inventories $ 1,377 Millions Visit WAT's Balance sheet
Waters's Cost of Revenues TTM $ 2,008 Millions Visit WAT's Income Statement
What are WAT's Sales? Visit WAT's Sales by Segment

Other Inventory Turnover Ratios
Waters's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
WAT's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for WAT's Competitors
Inventory Turnover Ratio for WAT's Suppliers
Inventory Turnover Ratio for WAT's Customers

You may also want to know
WAT's Sales Growth Rates WAT's Pe Price to earnings ratio WAT's Receivables Turnover Ratio WAT's Stock Quote
WAT's Net Income Growth Rates WAT's Ps Price to Sales ratio WAT's Sales per Employee WAT's Asset Turnover Ratio
WAT's Net Margin WAT's Pb Price to Book ratio WAT's Financial Strength Ratios WAT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 04 2026 Inventories at quarter ending Jul 04 2026
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions

Date modified: 2026-09-05T12:10:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.